Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway

Biomedicine and Pharmacotherapy

Volumn 68, Issue 8, 2014, Pages 1037-1043

  Zhang, Kun Shui ^a   Chen, Hui Qing ^b   Chen, Yi Shen ^c   Qiu, Kai Feng ^a   Zheng, Xiao Bin ^c   Li, Guo Cheng ^a   Yang, Hai Di ^a   Wen, Cui Ju ^b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Prevention and Treatment Center for Occupational Diseases   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

BPA; Lung cancer; Migration; MMP

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; PHENOL DERIVATIVE;

BIOSYNTHESIS; CELL MOTION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

BENZHYDRYL COMPOUNDS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; PHENOLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84916228111     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.09.003     Document Type: Article

References (48)

1. Brotons J.A., Olea-Serrano M.F., Villalobos M., Pedraza V., Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995, 103:608-612.
2. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
3. Le H.H., Carlson E.M., Chua J.P., Belcher S.M. Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol Lett 2008, 176:149-156.
4. Kang J.H., Kondo F., Katayama Y. Human exposure to bisphenol A. Toxicology 2006, 226:79-89.
5. Geens T., Aerts D., Berthot C., Bourguignon J.P., Goeyens L., Lecomte P., et al. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 2012, 50:3725-3740.
6. Li X., Ying G.G., Zhao J.L., Chen Z.F., Lai H.J., Su H.C. 4-Nonylphenol, bisphenol-A and triclosan levels in human urine of children and students in China, and the effects of drinking these bottled materials on the levels. Environ Int 2013, 52:81-86.
7. Carwile J.L., Luu H.T., Bassett L.S., Driscoll D.A., Yuan C., Chang J.Y., et al. Polycarbonate bottle use and urinary bisphenol a concentrations. Environ Health Perspect 2009, 117:1368-1372.
8. Rubin B.S. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011, 127:27-34.
9. Reck M., Heigener D.F., Mok T., Soria J.C., Rabe K.F. Management of non-small-cell lung cancer: recent developments. Lancet 2013, 382:709-719.
10. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2014, 63:11-30.
11. Couraud S., Zalcman G., Milleron B., Morin F., Souquet P.J. Lung cancer in never smokers-a review. Eur J Cancer 2012, 48:1299-1311.
12. Huang Y.Q., Wong C.K., Zheng J.S., Bouwman H., Barra R., Wahlstrom B., et al. (BPA) in China: a review of sources, environmental levels, and potential human health impacts. Environ Int 2012, 42:91-99.
13. Stabile L.P., Davis A.L.G., Gubish C.T., Hopkins T.M., Luketich J.D., Christie N., et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 2002, 62:2141-2150.
14. Hershberger P.A., Vasquez A.C., Kanterewicz B., Land S., Siegfried J.M., Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005, 65:1598-1605.
15. Schwartz A.G., Prysak G.M., Murphy V., Lonardo F., Pass H., Schwartz J., et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005, 11:7280-7287.
16. Chang C.Y., McDonnell D.P. Molecular pathways: the metabolic regulator estrogen-related receptor alpha as a therapeutic target in cancer. Clin Cancer Res 2012, 18:6089-6095.
17. Jala V.R., Radde B.N., Haribabu B., Klinge C.M. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer. BMC Cancer 2012, 12:624.
18. Petrier C., Torres-Palma R., Combet E., Sarantakos G., Baup S., Pulgarin C. Enhanced sonochemical degradation of bisphenol-A by bicarbonate ions. Ultrason Sonochem 2010, 17:111-115.
19. Sheng Z.G., Zhu B.Z. Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-alpha. Environ Health Perspect 2011, 119:1775-1780.
20. Polette M., Nawrocki-Raby B., Gilles C., Clavel C., Birembaut P. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 2004, 49:179-186.
21. Zhang W.L., Luo Y., Zhang L., Cai Q., Pan X.J. Known and emerging factors modulating estrogenic effects of endocrine-disrupting chemicals. Environ Rev 2014, 22:87-98.
22. Ptak A., Hoffman M., Gruca I., Barc J. Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways. Toxicol Lett 2014.
23. Xu X.H., Lu Y., Zhang G.X., Chen L., Tian D., Shen X.Y., et al. promotes dendritic morphogenesis of hippocampal neurons through estrogen receptor-mediated ERK1/2 signal pathway. Chemosphere 2014, 96:129-137.
24. Chung T.W., Lee Y.C., Kim C.H., Hepatitis B. viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERKs and PI-3K/AKT pathways: involvement of invasive potential. Faseb J 2004, 18. 1123-+.
25. Genersch E., Hayess K., Neuenfeld Y., Haller H., Sustained E.R.K. phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 2000, 23:4319-4330. 113 Pt.
26. Rezg R., El-Fazaa S., Gharbi N., Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014, 64:83-90.
27. Siegfried J.M., Stabile L.P. Estrongenic steroid hormones in lung cancer. Semin Oncol 2014, 41:5-16.
28. Smith-Bindman R. Environmental causes of breast cancer and radiation from medical imaging: findings from the Institute of Medicine report. Arch Intern Med 2012, 172:1023-1027.
29. Jenkins S., Wang J., Eltoum I., Desmond R., Lamartiniere C.A. Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 2011, 119:1604-1609.
30. Stabile L.P., Siegfried J.M. Estrogen receptor pathways in lung cancer. Curr Oncol Rep 2004, 6:259-267.
31. Dominguez M.A., Petre M.A., Neal M.S., Foster W.G., Bisphenol A. concentration-dependently increases human granulosa-lutein cell matrix metalloproteinase-9 (MMP-9) enzyme output. Reprod Toxicol 2008, 25:420-425.
32. Hung W.C., Tseng W.L., Shiea J., Chang H.C. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 2010, 288:156-161.
33. Albanito L., Lappano R., Madeo A., Chimento A., Prossnitz E.R., Cappello A.R., et al. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008, 116:1648-1655.
34. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007, 67:1859-1866.
35. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008, 70:165-190.
36. Dong S., Terasaka S., Kiyama R., Bisphenol A. induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ Pollut 2011, 159:212-218.
37. Chevalier N., Bouskine A., Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int J Cancer 2012, 130:241-242.
38. Ge L.C., Chen Z.J., Liu H.Y., Zhang K.S., Liu H., Huang H.B., et al. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor alpha/beta in low doses of bisphenol A promoting growth of Sertoli TM4 cells. Toxicol Lett 2014, 226:81-89.
39. Ptak A., Gregoraszczuk E.L. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell. Toxicol Lett 2012, 210:332-337.
40. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010, 1802:396-405.
41. Reddy K.B., Nabha S.M., Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003, 22:395-403.
42. Gao F., Ma X., Ostmann A.B., Das S.K. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERalpha) phosphorylation signals. Endocrinology 2011, 152:1434-1447.
43. Prossnitz E.R., Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011, 7:715-726.
44. Vivacqua A., Bonofiglio D., Albanito L., Madeo A., Rago V., Carpino A., et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006, 70:1414-1423.
45. Vivacqua A., Bonofiglio D., Recchia A.G., Musti A.M., Picard D., Ando S., et al. protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006, 20:631-646.
46. Yu T., Liu M., Luo H., Wu C., Tang X., Tang S., et al. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17beta-estradiol in triple-negative breast cancer cells. J Steroid Biochem Mol Biol 2014, 143C:392-403.
47. Zhang Z., Zhou D., Lai Y., Liu Y., Tao X., Wang Q., et al. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Lett 2012, 319:89-97.
48. Li Y., Wang J.P., Santen R.J., Kim T.H., Park H., Fan P., et al. Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology 2010, 151:5146-5156.